STOK today
$26.61+$0.41 (+1.56%)close Nov 13, 2026Trend
DailyUptrend (starting)
4 hourBearish
1 hourExpanding
15 minBullish
5 minStrong Bullish
Daily trend turns down below $22.05
Key levels
Resistance$28.43
Resistance$26.69
Support$24.52
Support$22.05
Latest news & SEC filings
EarningsStoke Therapeutics holds Q3 2026 earnings call
EarningsStoke Therapeutics Posts Q3 2026 Financials
All STOK news →About Stoke Therapeutics
Stoke Therapeutics is a clinical-stage biopharmaceutical company that creates RNA-based medicines to address the root causes of severe genetic disorders. Its most advanced therapy, zorevunersen, is undergoing late-phase testing for Dravet syndrome, a severe epilepsy. The company is also developing treatments for an inherited eye condition and other neurological disorders. It operates in the United States and the United Kingdom, and has a partnership with Biogen for development and commercialization in most regions outside North America.
Based on the company's 10-K filed Mar 16, 2026.
Nasdaq · Healthcare
Stoke Therapeutics, Inc. (STOK)
What Is the Price Target for STOK?
SEPT Low Target
$40.00
SEPT Mid Target
$42.00
SEPT High Target
$58.00
Analyst Consensus
$42.00
Is STOK a Buy or Sell Right Now?
Thesis
- •Revenue growing 404.5% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for STOK.
Start Free Trial →Is STOK Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, Analyst Consensus
Fair Value
$34.87
27
Moat Score
NONE
4/9
Piotroski Score
13.6
Altman Z-Score
What Is Smart Money Doing with STOK?
Insider Signal
SELLING
0 buys / 19 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Ticho Barry | officer | Sale | 6,995 | $185K | Nov 2, 2026 |
| Ticho Barry | officer | Sale | 200 | $5K | Nov 2, 2026 |
| Ticho Barry | officer | Sale | 1,795 | $55K | Jun 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →STOK Growth Story
Revenue YoY
404.5%
3yr Revenue CAGR
145.9%
EPS Growth YoY
92.73%
FCF Growth YoY
151.6%
Revenue Trend
ACCELERATING
Dark Pool Trades for STOK
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for STOK, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:43:47 | $26.49 | 1,189 | $$31K | SELL |
| 17:35:16 | $26.50 | 4,080 | $$108K | SELL |
| 17:01:31 | $26.36 | 3,000 | $$79K | MIDPOINT |
| 15:16:45 | $25.93 | 1,172 | $$30K | MIDPOINT |
| 14:58:28 | $25.93 | 5,612 | $$146K | MIDPOINT |
5 dark pool trades shown · $$395K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for STOK
PREVIEWSEPT Investing provides real-time options flow tracking for STOK, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $20 | Nov 20 | 7 | $$20 | 4 | SWEEP |
| PUT | $20 | Nov 20 | 7 | $$25 | 5 | SWEEP |
2 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Stoke Therapeutics, Inc. (STOK) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →STOK — frequently asked questions
What is STOK stock price today?
Stoke Therapeutics, Inc. (STOK) is at $26.61, up 1.56% (+$0.41) at the Nov 13, 2026 close.
Why is STOK stock moving today?
Latest STOK news — Oct 29, 2026: Stoke Therapeutics holds Q3 2026 earnings call · Oct 29, 2026: Stoke Therapeutics Posts Q3 2026 Financials
What is the STOK price target?
The average analyst price target for STOK is $42.00, ranging from $40 to $58, based on 4 analysts.
What do analysts rate STOK?
Analyst ratings for STOK: 0 Buy, 5 Hold, 0 Sell — consensus Hold.
Did STOK beat earnings?
STOK last reported on Oct 29, 2026: EPS -$1.08 vs -$0.93 expected — a miss of 16.2%.
Does STOK pay a dividend?
STOK does not currently pay a dividend.
What are STOK support and resistance levels?
Support: $24.52, $22.05. Resistance: $26.69, $28.43, $29.94.
What are insiders doing with STOK?
Insider activity: SELLING, 0 buys and 19 sells in the last 90 days.
What is the latest news on STOK?
Oct 29, 2026: Stoke Therapeutics holds Q3 2026 earnings call · Oct 29, 2026: Stoke Therapeutics Posts Q3 2026 Financials